These results demonstrate that NAT10 stabilizes ETS2 mRNA by catalyzing ac4C acetylation, thereby regulating PD-L1 expression and contributing to the immunosuppressive microenvironment of pancreatic cancer. The gene discussed is ETS2; the disease is pancreatic neoplasm.